Big Pharma Split (TSX:PRM) Debt-to-Revenue : 0.00 (As of Jun. 2024)

Big Pharma Split Debt-to-Revenue Chart

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Revenue	Get a 7-Day Free Trial									-	-	N/A	-	-

Competitive Comparison of Big Pharma Split's Debt-to-Revenue

For the Asset Management subindustry, Big Pharma Split's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Big Pharma Split's Debt-to-Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's Debt-to-Revenue falls into.

Big Pharma Split Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Big Pharma Split's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Big Pharma Split's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2024) Revenue data.

Big Pharma Split Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split Business Description